Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Noncontrolling Interest [Member]	Temporary Equity, Including Portion Attributable to Noncontrolling Interests [Member]	Common Stock Outstanding [Member]
Balance, temporary equity, including noncontrolling interest						$ 6,038	$ 6,038
Balance (in shares) at Dec. 31, 2023								184,652,402
Balance at Dec. 31, 2023	$ 218,806	$ 18	$ 667,881	$ (460,496)	$ 3,196	8,207
Proceeds from exercise of options (in shares)								1,385,363
Proceeds from exercise of options	3,334	0	3,334	0	0	0
Common stock issued upon vesting of restricted stock units (in shares)								3,030,973
Common stock issued upon vesting of restricted stock units	0	1	(1)	0	0	0
Stock-based compensation expense	19,996	0	19,996	0	0	0
Repurchase of noncontrolling interest	$ 0	0	6,379	0	2	(6,381)
Repurchase and retirement of common stock (in shares)	(2,411,432)							(2,411,432)
Repurchase and retirement of common stock	$ (19,150)	0	(8,844)	(10,306)	0	0
Net income	(14,887)		0	(14,624)	0	(263)
Unrealized loss on available-for-sale securities	(141)	0	0	0	(141)	0
Foreign currency translation adjustments	(391)	$ 0	0		(325)	(66)
Balance (in shares) at Jun. 30, 2024		186,657,306						186,657,306
Balance at Jun. 30, 2024	207,408	$ 19	688,487	(485,327)	2,732	1,497
Reclassification of earn-out RSUs to earn-out shares	(258)	$ 0	(258)		0	0
Accretion of redeemable noncontrolling interest	99			99		(99)	(99)
Redemption of noncontrolling interest						(5,926)	(5,926)
Net loss						(5)	(5)
Temporary Equity, Foreign Currency Translation Adjustments						(8)	(8)
Balance (in shares) at Mar. 31, 2024		185,215,633
Balance at Mar. 31, 2024	212,748	$ 19	677,926	(469,517)	2,693	1,627
Proceeds from exercise of options (in shares)		1,092,002
Proceeds from exercise of options	2,550	$ 0	2,550	0	0	0
Common stock issued upon vesting of restricted stock units (in shares)		1,002,253
Common stock issued upon vesting of restricted stock units	0	$ 0	0	0	0	0
Stock-based compensation expense	10,538	$ 0	10,538	0	0	0
Repurchase and retirement of common stock (in shares)		(652,582)
Repurchase and retirement of common stock	(5,407)	$ 0	(2,406)	(3,001)	0	0
Net income	(12,938)	0	0	(12,809)	0	(129)
Unrealized loss on available-for-sale securities	(41)	0	0	0	(41)	0
Foreign currency translation adjustments	79	$ 0	0	0	80	(1)
Balance (in shares) at Jun. 30, 2024		186,657,306						186,657,306
Balance at Jun. 30, 2024	207,408	$ 19	688,487	(485,327)	2,732	1,497
Reclassification of earn-out RSUs to earn-out shares	(121)	$ 0	(121)	0	0	0
Balance, temporary equity, including noncontrolling interest						0	$ 0
Balance (in shares) at Dec. 31, 2024		194,070,512
Balance at Dec. 31, 2024	$ 270,948	$ 19	779,007	(510,448)	576	1,794
Proceeds from exercise of options (in shares)	1,495,597	1,495,597
Proceeds from exercise of options	$ 8,029	$ 0	8,029	0	0	0
Common stock issued upon vesting of restricted stock units (in shares)		2,921,254
Common stock issued upon vesting of restricted stock units	0	$ 0	0	0	0	0
Stock-based compensation expense	20,763	$ 0	20,763	0	0	0
Repurchase of noncontrolling interest	(12,148)		(9,958)	0		(2,226)
Repurchase of noncontrolling interest					36
Reclassification of warrant liabilities	1,452		1,452	0	0	0
Proceeds from exercise of warrants (in shares)		13,866,954
Proceeds from exercise of warrants	$ 159,471	$ 2	159,469	0	0	0
Repurchase and retirement of common stock (in shares)	(1,215,323)	(1,215,323)
Repurchase and retirement of common stock	$ (18,953)	$ 0	(5,316)	(13,637)	0	0
Net income	6,459	0	0	6,138	0	321
Unrealized loss on available-for-sale securities	(17)	0	0	0	(17)	0
Foreign currency translation adjustments	7,131	$ 0	0	0	7,020	111
Balance (in shares) at Jun. 30, 2025		211,138,994
Balance at Jun. 30, 2025	443,135	$ 21	953,446	(517,947)	7,615	0
Balance (in shares) at Mar. 31, 2025		203,030,980
Balance at Mar. 31, 2025	361,453	$ 20	873,269	(515,468)	1,682	1,950
Proceeds from exercise of options (in shares)		1,077,228
Proceeds from exercise of options	7,285	$ 0	7,285	0	0	0
Common stock issued upon vesting of restricted stock units (in shares)		1,173,259
Common stock issued upon vesting of restricted stock units	0	$ 0	0	0	0	0
Stock-based compensation expense	11,143	0	11,143	0	0	0
Repurchase of noncontrolling interest	(12,148)	0	(9,958)	0		(2,226)
Repurchase of noncontrolling interest					36
Reclassification of warrant liabilities	1,452	$ 0	1,452	0	0	0
Proceeds from exercise of warrants (in shares)		6,271,855
Proceeds from exercise of warrants	72,127	$ 1	72,126	0	0	0
Repurchase and retirement of common stock (in shares)		(414,328)
Repurchase and retirement of common stock	(7,048)	$ 0	(1,871)	(5,177)	0	0
Net income	2,893	0	0	2,698	0	195
Unrealized loss on available-for-sale securities	(5)	0	0	0	(5)	0
Foreign currency translation adjustments	5,983	$ 0	0	0	5,902	81
Balance (in shares) at Jun. 30, 2025		211,138,994
Balance at Jun. 30, 2025	$ 443,135	$ 21	$ 953,446	$ (517,947)	$ 7,615	$ 0